Deals Rumor Mill: Intercept Pharma, Barclays, Banco Poplare
Liver disease treatment developer Intercept Pharmaceuticals Inc. is mulling a sale, Reuters reported on Friday, after having been approached by at least a couple of potential buyers. According to the report,...To view the full article, register now.
Already a subscriber? Click here to view full article